IL84980A - Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins, their preparation and use - Google Patents

Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins, their preparation and use

Info

Publication number
IL84980A
IL84980A IL84980A IL8498087A IL84980A IL 84980 A IL84980 A IL 84980A IL 84980 A IL84980 A IL 84980A IL 8498087 A IL8498087 A IL 8498087A IL 84980 A IL84980 A IL 84980A
Authority
IL
Israel
Prior art keywords
aids
preparation
synthetic peptides
viral proteins
cellular immunity
Prior art date
Application number
IL84980A
Other languages
English (en)
Other versions
IL84980A0 (en
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IL84980A0 publication Critical patent/IL84980A0/xx
Publication of IL84980A publication Critical patent/IL84980A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL84980A 1986-12-30 1987-12-29 Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins, their preparation and use IL84980A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94793586A 1986-12-30 1986-12-30
US1443087A 1987-02-12 1987-02-12

Publications (2)

Publication Number Publication Date
IL84980A0 IL84980A0 (en) 1988-06-30
IL84980A true IL84980A (en) 1993-06-10

Family

ID=26686083

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84980A IL84980A (en) 1986-12-30 1987-12-29 Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins, their preparation and use

Country Status (7)

Country Link
EP (1) EP0273716B1 (fr)
JP (1) JPH0762031B2 (fr)
AU (1) AU592258B2 (fr)
CA (1) CA1340896C (fr)
DE (1) DE3787002T2 (fr)
IL (1) IL84980A (fr)
WO (1) WO1988005051A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
US5939074A (en) * 1986-12-30 1999-08-17 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptide antigens
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
ES2102347T3 (es) * 1987-02-20 1997-08-01 Genentech Inc Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
WO1989002277A2 (fr) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxie et therapie du syndrome immunodeficitaire acquis
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
WO1989007112A1 (fr) * 1988-01-26 1989-08-10 The United States Of America, As Represented By Th Antigene synthetique suscitant une reaction anti-vih
US5820865A (en) * 1988-01-26 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
CA1341285C (fr) * 1988-02-12 2001-08-14 Chang Yi Wang Peptides synthetiques servant a la detection d'anticorps de la proteine de surface gp120 du virus hiv, destines au diagnostic du sida, ainsi que d'etats pre-sidatiques, ou aux fins de vaccins
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5185147A (en) * 1988-08-19 1993-02-09 Cellular Products, Inc. Short polypeptide sequences useful in the production and detection of antibodies against human immunodeficiency virus
EP0362909A3 (fr) * 1988-08-26 1990-11-14 Akzo N.V. Polypeptides synthétiques immuno-actifs avec des anticorps VIH
EP0436634A1 (fr) * 1988-10-03 1991-07-17 Repligen Corporation Proteines et peptides du vih utiles pour le diagnostic, la prophylaxie ou la therapie du sida
FR2640877A1 (fr) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
CA2025634A1 (fr) * 1989-09-19 1991-03-20 Thomas Fuerst Peptides comprenant des epitopes ctl de proteines de hiv et leur utilisation
WO1991004273A2 (fr) * 1989-09-22 1991-04-04 Idec Pharmaceuticals Corp. Nouveaux peptides associes a la region de liaison cd4 de la gp120 et leur mode d'emploi
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
WO1992021377A1 (fr) * 1991-06-03 1992-12-10 Syntello Inc. Peptides a utiliser pour induire l'activation de lymphocytes t contre le vih-1
FR2677654B1 (fr) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
CA2114849C (fr) * 1991-08-29 2007-04-24 Jay A. Berzofsky Antigenes peptidiques multideterminants qui stimulent la reponse des lymphocytes t auxiliaires contre le hiv chez une gamme de sujets humains
AU679439B2 (en) * 1992-02-10 1997-07-03 Duke University Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5607914A (en) * 1993-01-13 1997-03-04 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
ES2293643T5 (es) * 1994-10-20 2012-02-02 Institut Pasteur Secuencias nucleotídicas de antígenos retrovíricos vih-1 del grupo (o subgrupo) o.
US5714577A (en) * 1996-01-26 1998-02-03 University Of Pittsburgh Antimicrobial peptides
WO2000076537A2 (fr) * 1997-09-10 2000-12-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Utilisation de complexes de peptide-lignee cellulaire semi-allogenique§ pour le traitement du cancer, du sida et d'autres maladies virales
US6749856B1 (en) 1997-09-11 2004-06-15 The United States Of America, As Represented By The Department Of Health And Human Services Mucosal cytotoxic T lymphocyte responses
HK1044040A1 (zh) 1998-11-16 2002-10-04 德克萨斯州立大学董事会 Hiv-特异的t-细胞诱导
AU3774000A (en) * 1999-03-29 2000-10-16 David Bernstein Conformationally constrained peptides
IL150961A0 (en) * 2000-02-04 2003-02-12 Univ Duke Human immunodeficiency virus vaccine
JP4419549B2 (ja) 2003-07-18 2010-02-24 東レ株式会社 極細短繊維不織布および皮革様シート状物ならびにそれらの製造方法
AU2006214563B2 (en) 2005-02-15 2011-08-18 Thymon, L.L.C. Methods and compositions for impairing multiplication of HIV-1
WO2009012143A2 (fr) 2007-07-13 2009-01-22 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Peptides antimicrobiens dérivés de virus
WO2015127444A1 (fr) * 2014-02-24 2015-08-27 Georgetown University Inhibiteur compétitif de la gp120
WO2021092382A1 (fr) 2019-11-08 2021-05-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions comprenant des peptides antimicrobiens
US12371463B2 (en) 2021-04-20 2025-07-29 University of Pittsburgh—of the Commonwealth System of Higher Education Methods and compositions for treatment of antibiotic-resistant bacterial infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
WO1986001834A1 (fr) * 1984-09-19 1986-03-27 The Regents Of The University Of California Polypeptides retroviraux associes a la transformation de cellules humaines
WO1986002383A1 (fr) * 1984-10-18 1986-04-24 Institut Pasteur Antigenes d'enveloppe du virus des lymphadenopathies et leurs applications
CA1340878C (fr) * 1984-10-26 2000-01-25 Takis S. Papas Production bacterienne de fragments de proteine de l'enveloppe du retrovirus de la leucemie (lymphotropique) des cellules t de l'humain (htlu-i), que son usage dans le depisage seroepidemiologique de tumeurs malignes lymphatiques chez les humains
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease

Also Published As

Publication number Publication date
AU1365788A (en) 1988-07-27
WO1988005051A1 (fr) 1988-07-14
EP0273716A2 (fr) 1988-07-06
IL84980A0 (en) 1988-06-30
JPS63503227A (ja) 1988-11-24
EP0273716B1 (fr) 1993-08-11
DE3787002T2 (de) 1993-11-25
AU592258B2 (en) 1990-01-04
EP0273716A3 (en) 1989-12-20
DE3787002D1 (de) 1993-09-16
CA1340896C (fr) 2000-02-15
JPH0762031B2 (ja) 1995-07-05

Similar Documents

Publication Publication Date Title
EP0273716A3 (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
ATA257190A (de) Virales polypeptid
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
EP0128762A3 (en) New hypotensive peptides, their preparation and their use
DK603888A (da) Rekombinant virus
FR2620459B1 (fr) Virus recombinant de la vaccine
ZA862812B (en) Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
EP0525828A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
OA09152A (en) Synthetic peptides related to HIV-ENV proteins.
EP0970115A4 (fr) Peptides viraux presentant une homologie structurelle avec la proteine g du virus respiratoire syncytial bovin
KR920700222A (ko) 동결건조된 펩티드 제제
GR3034271T3 (en) Pseudorabies virus protein.
DK698188A (da) Peptider, deres fremstilling og anvendelse
ZA905296B (en) Use of bluetongue virus proteins as vaccines components
EP0311228A3 (fr) Polypeptides recombinants et leur utilisation, y compris un diagnostic pour le virus du SIDA
NZ230459A (en) Method of purifying the ha2 subunit of the influenza virus ha protein
AU7492087A (en) Newcastle disease virus protein
AU1216988A (en) Immunogenic fusion proteins which contain Epstein-Barr virus protein
ZA876168B (en) Human low fc epsilon-receptor,the isolation,the recombinant preparation and purification thereof
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
EP0244427A4 (fr) Virus recombinant.
IE881635L (en) Human immunodeficiency virus gag-encoded proteins

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired